Stay updated on Daratumumab Post-Transplant in Multiple Myeloma Clinical Trial

Sign up to get notified when there's something new on the Daratumumab Post-Transplant in Multiple Myeloma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Daratumumab Post-Transplant in Multiple Myeloma Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The screenshots show minor administrative updates to the study page (such as the last update timestamp and formatting tweaks) with no changes to the core study details, eligibility criteria, outcomes, or contacts. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-03T21:28:32.000Z thumbnail image
  2. Check
    8 days ago
    No Change Detected
  3. Check
    30 days ago
    Change Detected
    Summary
    Added a government funding operation-status notice and updated version to v3.2.0; removed the AA amyloidosis resource and the old v3.1.0 tag.
    Difference
    3%
    Check dated 2025-10-06T07:54:05.000Z thumbnail image
  4. Check
    37 days ago
    Change Detected
    Summary
    Update to v3.1.0 with removal of the term 'Plasma cell myeloma' from the content. Mostly a version bump with a minor deletion; no clear major content or feature changes detected.
    Difference
    0.2%
    Check dated 2025-09-29T04:13:01.000Z thumbnail image
  5. Check
    51 days ago
    Change Detected
    Summary
    Revision: v3.0.2 replaces v3.0.1; the 'Back to Top' element was removed. No other core content, pricing, stock, or time-slot details appear to be affected.
    Difference
    0.2%
    Check dated 2025-09-14T21:51:50.000Z thumbnail image
  6. Check
    58 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.
    Difference
    0.2%
    Check dated 2025-09-07T18:47:48.000Z thumbnail image
  7. Check
    65 days ago
    Change Detected
    Summary
    The web page has been updated to include new facility names and locations, as well as additional resources related to various diseases and therapies. Notably, the previous mention of 'Multiple Myeloma' has been removed, indicating a shift in focus.
    Difference
    5%
    Check dated 2025-08-31T12:27:40.000Z thumbnail image

Stay in the know with updates to Daratumumab Post-Transplant in Multiple Myeloma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Daratumumab Post-Transplant in Multiple Myeloma Clinical Trial page.